324
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Clinical Audit on Chronic Obstructive Pulmonary Disease (COPD) Management in Primary Care: A Quality Improvement Project from Hong Kong

, ORCID Icon, , , , , , , , , , , & show all
Pages 1901-1911 | Published online: 23 Jun 2021

References

  • Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/S0140-6736(17)31222-9
  • World Health Organization. Chronic Obstructive Pulmonary Disease (COPD). Geneva; 2016.
  • Department of Health. Population Health Survey 2014/15. Hong Kong SAR:Department of Health; 2015.
  • Hospital Authority, Department of Health and Census and Statistics Department. Inpatient Statistics 2016. Hong Kong SAR:Hospital Authority, Department of Health and Census and Statistics Department; 2016.
  • Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994;272(19):1497–1505. doi:10.1001/jama.1994.03520190043033
  • Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet. 2009;374:721–732. doi:10.1016/S0140-6736(09)61290-3
  • Bekkat-Berkani R, Wilkinson T, Buchy P, et al. Seasonal influenza vaccination in patients with COPD: a systematic literature review. BMC Pulm Med. 2017;17(1):79. doi:10.1186/s12890-017-0420-8
  • Walters JA, Tang JN, Poole P, Wood-Baker R. Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;1(1):CD001390.
  • Kester S, Chapman KR. Physician perceptions and management of COPD. Chest. 1993;104:254–258. doi:10.1378/chest.104.1.254
  • Jiménez-Ruiz CA, Masa F, Miravitlles M, et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest. 2001;119(5):1365–1370. doi:10.1378/chest.119.5.1365
  • Miriam J, Evelien ES, Frans H. Smoking cessation strategies in patients with COPD. Eur Respir J. 2013;41:727–734. doi:10.1183/09031936.00014012
  • Ciblak MA, Platformu G. Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate. Vaccine. 2013;31:518–523. doi:10.1016/j.vaccine.2012.11.022
  • European Centre for disease prevention and control (ECDC). Seasonal influenza vaccination in Europe - overview of vaccination recommendations and coverage rates in the EU member states for the 2012–2013 influenza season, technical report. Eur Centre Dis Prev Control. 2015.
  • Centers for disease control and prevention (CDC). Flu vaccination coverage, United States, 2014–15 influenza season; 2016. Available from: http://www.cdc.gov/flu/fluvaxview/coverage-1415estimates.htm. Accessed 31 January 2019.
  • Chronic obstructive pulmonary disease. MOH Singapore clinical practice guidelines 2/2017.
  • Qureshi H, Sharafkhaneh A, Hanania NA. Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications. Ther Adv Chronic Dis. 2014;5(5):212–227. doi:10.1177/2040622314532862
  • Statistics and Workforce Planning Department. Strategy and Planning Division. Hospital Authority. Hospital Authority Statistical Report 2017–2018. HKSAR: Hospital Authority; 2018.
  • Yu WC, Tai EL, Fu SN, et al. Treatment of patients with chronic obstructive pulmonary disease as practised in a defined Hong Kong community: a cross-sectional pilot survey. Hong Kong Med J. 2011;17(4):306–314.
  • Yu WC, Fu SN, Tai EL, et al. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis. 2013;8:389–395. doi:10.2147/COPD.S48659
  • Chan KP, Ko FW, Chan HS, et al. Adherence to a COPD treatment guideline among patients in Hong Kong. Int J Chron Obstruct Pulmon Dis. 2017;12:3371–3379. doi:10.2147/COPD.S147070
  • Chan HS, Ko FWS, Chan JWM, et al. Comorbidities, mortality, and management of chronic obstructive pulmonary disease patients who required admissions to public hospitals in Hong Kong - computerized data collection and analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1913–1925. doi:10.2147/COPD.S163659
  • Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2017 report). Available from: https://goldcopd.org/wp-content/uploads/2016/12/wms-GOLD-2017-Pocket-Guide.pdf. Accessed June 8, 2021.
  • Chronic obstructive pulmonary disease in over 16s: diagnosis and management. National Institute for Health and Care Excellence Guideline (NG115), published 05 December 2018.
  • National Asthma and Chronic Obstructive Pulmonary Disease Audit Programme (NACAP). Wales primary care clinical audit 2020 Clinical audit report Published March 2021. 2021
  • Xie M, Liu X, Cao X, et al. Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017. Respir Res. 2020;21:49. doi:10.1186/s12931-020-1291-8
  • Thematic Household Survey Report No. 64. Census and Statistics Department, Hong Kong Special Administrative Region; 2018. Available from: https://www.statistics.gov.hk/pub/B11302642018XXXXB0100.pdf. Accessed June 8, 2021.
  • Meredith LS, Yano EM, Hickey SC, Sherman SE. Primary care provider attitudes are associated with smoking cessation counseling and referral. Med Care. 2005;43(9):929–934. doi:10.1097/01.mlr.0000173566.01877.ac
  • Babb S, Malarcher A, Schauer G, Asman KAJ. Quitting smoking among adults—United States, 2000–2015. Morb Mortal Wkly Rep. 2017;65:1457–1464. doi:10.15585/mmwr.mm6552a1
  • Health and Social Care Information Centre. Statistics on NHS Stop Smoking Services in England: April 2014 to March 2015. Leeds, UK: Health and Social Care Information Centre; 2015.
  • Census and Statistics Department. Thematic Household Survey, Report No. 64: Pattern of Smoking. Hong Kong SAR: Hong Kong SAR Government; 2018.
  • Van Eerd EAM, Bech Risør M, Spigt M, et al. Why do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative study. NPJ Prim Care Respir Med. 2017;27(1):41. doi:10.1038/s41533-017-0038-6
  • Mittmann N, Kuramoto L, Seung SJ, et al. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med. 2008;102(3):413–421. doi:10.1016/j.rmed.2007.10.010
  • Lim S, Lam DC, Muttalif AR, et al. Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med. 2015;14:4. doi:10.1186/s12930-015-0020-9
  • Chen XRC, Leung SH, Li YC. Chronic Obstructive Pulmonary Disease (COPD) management in the community: how could primary care team contribute? BMC Fam Pract. BMC Family Practice. 2020;21(1):184. doi:10.1186/s12875-020-01256-0
  • Maricoto T, Monteiro L, Gama JMR, et al. Inhaler Technique Education and Exacerbation Risk in Older Adults with Asthma or Chronic Obstructive Pulmonary Disease: a Meta-Analysis. J Am Geriatr Soc. 2019;67(1):57–66. doi:10.1111/jgs.15602
  • Wedzicha JA. COPD exacerbations: defining their cause and prevention. The lancet. 2007;310(9589):786–796. doi:10.1016/S0140-6736(07)61382-8